Rachel E. Hayden
- Molecular Biology
- Cell Biology top 10%
- Cancer Research
- Pediatrics, Perinatology and Child Health
- Hematology
- Co-authors
- Christopher M. BunceMark T. DraysonJ.P. RideFarhat L. KhanimNicholas DaviesJane BirtwistleJoanne C. MountfordQuang T. Luong
- Topics
- Aldose Reductase and Taurine (4 papers)Histone Deacetylase Inhibitors Research (3 papers)Acute Myeloid Leukemia Research (2 papers)
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Rachel E. Hayden
14 papers receiving 572 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 349
- Cell Biology 198
- Cancer Research 108
- Pediatrics, Perinatology and Child Health 72
- Hematology 65
Countries citing papers authored by Rachel E. Hayden
This map shows the geographic impact of Rachel E. Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Hayden more than expected).
Fields of papers citing papers by Rachel E. Hayden
This network shows the impact of papers produced by Rachel E. Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Hayden. The network helps show where Rachel E. Hayden may publish in the future.
Co-authorship network of co-authors of Rachel E. Hayden
This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Hayden. A scholar is included among the top collaborators of Rachel E. Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Hayden. Rachel E. Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 5 | |
| 3 | 32 | |
| 4 | 16 | |
| 5 | 28 | |
| 6 | 32 | |
| 7 | 18 | |
| 8 | 68 | |
| 9 | 63 | |
| 10 | 53 | |
| 11 | 17 | |
| 12 | 72 | |
| 13 | 1 | |
| 14 | The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. | 131 |
About Rachel E. Hayden
Rachel E. Hayden is a scholar working on Genetics, Hematology and Cell Biology, having authored 14 papers that have together received 579 indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Cell Biology (198 citations), Cancer Research (108 citations) and Hematology (65 citations). Rachel E. Hayden has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Christopher M. Bunce, Mark T. Drayson, J.P. Ride, Farhat L. Khanim, Nicholas Davies, Jane Birtwistle, Joanne C. Mountford, Quang T. Luong, Richard M. Green and Julian C. Desmond. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.